Filing Flows › BioAge Labs (BIOA) › Q2 2026
BioAge Labs (BIOA) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
BioAge Labs (BIOA) reported revenue of $2.5M for the second quarter 2026 (Q2 2026), +2% from a year earlier and -12% from the quarter before.
BioAge Labs, Q2 2026: revenue $2.5M (+2% year over year), net loss $26.1M, operating cash flow −$19.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | -12% | +2% |
| Operating profit | −$29.3M | — | — |
| Net earnings | −$26.1M | — | — |
| Operating cash flow | −$19.3M | — | — |
What changed
Revenue was $2.5M in Q2 2026, up 2% year over year and down 12% from the previous quarter.
Operating costs exceeded revenue by $29.3M, an operating margin of -1196.8%. Total costs grew 17% against revenue growth of 2%. The fastest-growing cost line was Research & development (+23%). The quarter ended with a net loss of $26.1M, wider than the previous quarter's $22.3M loss.
Operating cash flow was −$19.3M. Non-cash charges added back $4.3M of share-based compensation. Working capital and other items added $2.6M. Capital expenditures of $328K exceeded it, leaving free cash flow of −$19.6M.
Questions
What was BioAge Labs' revenue in the second quarter 2026?
BioAge Labs (BIOA) reported revenue of $2.5M for the second quarter 2026 (Q2 2026), +2% from a year earlier and -12% from the quarter before.
Source: BioAge Labs 10-Q on SEC EDGAR.